Pages that link to "Q43952396"
Jump to navigation
Jump to search
The following pages link to Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor (Q43952396):
Displaying 50 items.
- Regulation of bone morphogenetic protein signalling in human pulmonary vascular development (Q24300001) (← links)
- Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutations (Q24303490) (← links)
- Molecular pathogenesis of pulmonary arterial hypertension (Q24634317) (← links)
- Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension (Q25255715) (← links)
- Pulmonary hypertension (Q26765376) (← links)
- BMPR2 spruces up the endothelium in pulmonary hypertension (Q26786834) (← links)
- Pathobiology of pulmonary arterial hypertension and right ventricular failure (Q26821779) (← links)
- BMPs and their clinical potentials (Q26824827) (← links)
- Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease (Q26859449) (← links)
- The molecular genetics and cellular mechanisms underlying pulmonary arterial hypertension (Q26992278) (← links)
- A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet? (Q27026643) (← links)
- The genetics of pulmonary arterial hypertension (Q27027507) (← links)
- Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats (Q27313498) (← links)
- Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation (Q27687091) (← links)
- Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series) (Q28078976) (← links)
- AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension (Q28118456) (← links)
- SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis (Q28118787) (← links)
- Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension (Q28534831) (← links)
- Bone morphogenetic protein 4 enhances canonical transient receptor potential expression, store-operated Ca2+ entry, and basal [Ca2+]i in rat distal pulmonary arterial smooth muscle cells (Q28569097) (← links)
- The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro (Q28570134) (← links)
- Hypoxia induces alteration of bone morphogenetic protein receptor signaling in pulmonary artery endothelial cell (Q28571377) (← links)
- Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension (Q28572271) (← links)
- PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension (Q28578858) (← links)
- Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice (Q28590362) (← links)
- A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects (Q30544892) (← links)
- Pulmonary arterial hypertension: the clinical syndrome (Q30583630) (← links)
- Genetics of pulmonary arterial hypertension: recent data and practical applications (Q31016276) (← links)
- BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production (Q31047574) (← links)
- MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension (Q32884516) (← links)
- Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension (Q33265315) (← links)
- Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva (Q33685088) (← links)
- Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension (Q33784417) (← links)
- Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension (Q33898213) (← links)
- Heritable forms of pulmonary arterial hypertension (Q33915567) (← links)
- Role of somatic mutations in vascular disease formation (Q34059841) (← links)
- Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy (Q34215319) (← links)
- BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism (Q34293026) (← links)
- Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension (Q34402401) (← links)
- Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension (Q34468421) (← links)
- An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension (Q34589929) (← links)
- Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollution (Q34782588) (← links)
- New perspectives for the treatment of pulmonary hypertension (Q34903204) (← links)
- Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension (Q34958933) (← links)
- Combination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats (Q35024562) (← links)
- Pulmonary arterial dysfunction in insulin resistant obese Zucker rats (Q35035330) (← links)
- Insights into the genetic and molecular basis of primary pulmonary hypertension. (Q35079425) (← links)
- Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival (Q35187029) (← links)
- Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation (Q35311990) (← links)
- BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension (Q35376926) (← links)
- Protein trafficking dysfunctions: Role in the pathogenesis of pulmonary arterial hypertension (Q35412349) (← links)